A citation-based method for searching scientific literature

Gardenia Vargas-Parra, Jesús Del Valle, Paula Rofes, Mireia Gausachs, Agostina Stradella, José M Moreno-Cabrera, Angela Velasco, Eva Tornero, Mireia Menéndez, Xavier Muñoz, Silvia Iglesias, Adriana López-Doriga, Daniel Azuara, Olga Campos, Raquel Cuesta, Esther Darder, Rafael de Cid, Sara González, Alex Teulé, Matilde Navarro, Joan Brunet, Gabriel Capellá, Marta Pineda, Lídia Feliubadaló, Conxi Lázaro. Hum Mutat 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet,[...]. Genet Med 2018
33
100

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
100

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
155
100

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
707
100


Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
21
100

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
100

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
Daniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, Tu Nguyen-Dumont, Nivonirina Robinot, Fleur Hammet, Fabrice Odefrey, Helen Tsimiklis, Zhi L Teo, Louise B Thingholm,[...]. Cancer Discov 2014
32
100

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
100

A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Chunling Hu, Steven N Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y Lee, Jie Na, Chi Gao, Jenna Lilyquist, Siddhartha Yadav, Nicholas J Boddicker,[...]. N Engl J Med 2021
39
100

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
100

ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Anne-Laure Renault, Fabienne Lesueur, Yan Coulombe, Stéphane Gobeil, Penny Soucy, Yosr Hamdi, Sylvie Desjardins, Florence Le Calvez-Kelm, Maxime Vallée, Catherine Voegele,[...]. PLoS One 2016
4
100

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
181
100

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Sean V Tavtigian, Peter J Oefner, Davit Babikyan, Anne Hartmann, Sue Healey, Florence Le Calvez-Kelm, Fabienne Lesueur, Graham B Byrnes, Shu-Chun Chuang, Nathalie Forey,[...]. Am J Hum Genet 2009
119
100

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Marjanka K Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, Muriel A Adank, Hanne Meijers, Quinten Waisfisz, Antoinette Hollestelle, Mieke Schutte,[...]. J Clin Oncol 2016
74
100

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Elodie Girard, Séverine Eon-Marchais, Robert Olaso, Anne-Laure Renault, Francesca Damiola, Marie-Gabrielle Dondon, Laure Barjhoux, Didier Goidin, Vincent Meyer, Dorothée Le Gal,[...]. Int J Cancer 2019
22
100

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Francesca Damiola, Maroulio Pertesi, Javier Oliver, Florence Le Calvez-Kelm, Catherine Voegele, Erin L Young, Nivonirina Robinot, Nathalie Forey, Geoffroy Durand, Maxime P Vallée,[...]. Breast Cancer Res 2014
64
100

"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.
Chrystelle Colas, Lisa Golmard, Antoine de Pauw, Sandrine M Caputo, Dominique Stoppa-Lyonnet. Breast 2019
13
100

A general framework for estimating the relative pathogenicity of human genetic variants.
Martin Kircher, Daniela M Witten, Preti Jain, Brian J O'Roak, Gregory M Cooper, Jay Shendure. Nat Genet 2014
100

The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.
Gisella Figlioli, Anders Kvist, Emma Tham, Jana Soukupova, Petra Kleiblova, Taru A Muranen, Nadine Andrieu, Jacopo Azzollini, Judith Balmaña, Alicia Barroso,[...]. Cancers (Basel) 2020
4
100

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
100

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull,[...]. J Natl Cancer Inst 2020
21
100

Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study.
Florence Le Calvez-Kelm, Fabienne Lesueur, Francesca Damiola, Maxime Vallée, Catherine Voegele, Davit Babikyan, Geoffroy Durand, Nathalie Forey, Sandrine McKay-Chopin, Nivonirina Robinot,[...]. Breast Cancer Res 2011
58
100

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
Sarah M Nielsen, Diana M Eccles, Iris L Romero, Fahd Al-Mulla, Judith Balmaña, Michela Biancolella, Rien Bslok, Maria Adelaide Caligo, Mariarosaria Calvello, Gabriele Lorenzo Capone,[...]. JCO Precis Oncol 2018
12
100

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
Jan P Schouten, Cathal J McElgunn, Raymond Waaijer, Danny Zwijnenburg, Filip Diepvens, Gerard Pals. Nucleic Acids Res 2002
100

Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.
K Lange, D Weeks, M Boehnke. Genet Epidemiol 1988
561
100

[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Jessica Moretta, Pascaline Berthet, Valérie Bonadona, Olivier Caron, Odile Cohen-Haguenauer, Chrystelle Colas, Carole Corsini, Véronica Cusin, Antoine De Pauw, Capucine Delnatte,[...]. Bull Cancer 2018
14
100

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Paolo Peterlongo, Irene Catucci, Mara Colombo, Laura Caleca, Eliseos Mucaki, Massimo Bogliolo, Maria Marin, Francesca Damiola, Loris Bernard, Valeria Pensotti,[...]. Hum Mol Genet 2015
59
100

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
100

Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.
Bernard Bonaïti, Valérie Bonadona, Hervé Perdry, Nadine Andrieu, Catherine Bonaïti-Pellié. Eur J Hum Genet 2011
6
100

Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
Henry T Lynch, Carrie L Snyder, Jane F Lynch, Bronson D Riley, Wendy S Rubinstein. J Clin Oncol 2003
35
100

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
Leila Dorling, Sara Carvalho, Jamie Allen, Anna González-Neira, Craig Luccarini, Cecilia Wahlström, Karen A Pooley, Michael T Parsons, Cristina Fortuno, Qin Wang,[...]. N Engl J Med 2021
49
100

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?
A K d'Almeida, E Cavaciuti, M-G Dondon, A Laugé, N Janin, D Stoppa-Lyonnet, N Andrieu. Br J Cancer 2005
5
100

Rare mutations in XRCC2 increase the risk of breast cancer.
D J Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, S L Neuhausen, E M John, I L Andrulis, M B Terry,[...]. Am J Hum Genet 2012
115
100

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.
Lisa Golmard, Laurent Castéra, Sophie Krieger, Virginie Moncoutier, Khadija Abidallah, Henrique Tenreiro, Anthony Laugé, Julien Tarabeux, Gael A Millot, André Nicolas,[...]. Eur J Hum Genet 2017
18
100

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
77
100

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.
Melissa C Southey, Daniel J Park, Tu Nguyen-Dumont, Ian Campbell, Ella Thompson, Alison H Trainer, Georgia Chenevix-Trench, Jacques Simard, Martine Dumont, Penny Soucy,[...]. Breast Cancer Res 2013
26
100

Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
Federica Casilli, Zorika Christiana Di Rocco, Sophie Gad, Isabelle Tournier, Dominique Stoppa-Lyonnet, Thierry Frebourg, Mario Tosi. Hum Mutat 2002
146
100

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca, Sandra Viz Lasheras, Roser Pujol, Johanna I Kiiski, Taru A Muranen, Daniel R Barnes, Joe Dennis,[...]. NPJ Breast Cancer 2019
12
100

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.